Safety and Performance Study of the Harpoon Mitral Valve Repair System

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

June 16, 2017

Study Completion Date

April 20, 2018

Conditions
Mitral Valve RegurgitationMitral Valve ProlapseMitral Valve Insufficiency
Interventions
DEVICE

Harpoon Artificial ePTFE Chords

The Harpoon Medical Transapical device is intended to be used to reduce the degree of degenerative mitral regurgitation by delivering and anchoring one or more ePTFE cords to the affected mitral valve leaflet(s) via a small left thoracotomy on the beating heart in patients with anterior, bi-leaflet or posterior prolapse.

Trial Locations (2)

Unknown

Jagiellonian University, Krakow

04-628

Instytut of Kardiologii & Transplantology, Warsaw

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY